Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the efficacy and safety of dupilumab in adult patients with bullous pemphigoid has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Bullous Pemphigoid | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-03-06